Clinical trials during the Ebola crisis

Abstract

Get full access to this article

View all access options for this article.

References

World Health Organization. Ebola situation report, 11 November 2015, http://apps.who.int/ebola/current-situation/ebola-situation-report-11-november-2015 (accessed 17 November 2015).

The World Bank Group. GDP per capita, PPP (current international $). World Development Indicators database, http://data.worldbank.org/indicator/NY.GDP.PCAP.PP.CD?order=wbapi_data_value_2014+wbapi_data_value+wbapi_data_value-last&sort=desc (2015, accessed 17 November 2015).

Jahrling

Hensley

Barrett

. State-of-the-art workshops on medical countermeasures potentially available for human use following accidental exposures to Ebola virus. J Infect Dis 2015; 212(Suppl. 2): S84–S90.

Kuhn

. Filoviruses: a compendium of 40 years of epidemiological, clinical and laboratory studies. 1st ed. New York: Springer Wien, p. 81.

Kuhn

Dodd

Wahl-Jensen

. Evaluation of perceived threat differences posed by filovirus variants. Biosecur Bioterror 2011; 9: 361–371.